Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S A Luykx"'
Autor:
Tjeerd J. Postma, Martin J.B. Taphoorn, B A Zonnenberg, Martin Klein, Jan B. Vermorken, Otto S. Hoekstra, Jan J. Heimans, L F Beenen, C.J. van Groeningen, S A Luykx
Publikováno v:
Annals of Oncology, 11(4), 409-413. Oxford University Press
Postma, T J, Heimans, J J, Luykx, S A, Van Groeningen, C J, Beenen, L F M, Hoekstra, O S, Taphoorn, M J B, Zonnenberg, B A, Klein, M & Vermorken, J B 2000, ' A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma ', Annals of Oncology, vol. 11, no. 4, pp. 409-413 . https://doi.org/10.1023/A:1008376123066
Annals of oncology, 11(4), 409-413. Oxford University Press
Annals of oncology
Postma, T J, Heimans, J J, Luykx, S A, Van Groeningen, C J, Beenen, L F M, Hoekstra, O S, Taphoorn, M J B, Zonnenberg, B A, Klein, M & Vermorken, J B 2000, ' A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma ', Annals of Oncology, vol. 11, no. 4, pp. 409-413 . https://doi.org/10.1023/A:1008376123066
Annals of oncology, 11(4), 409-413. Oxford University Press
Annals of oncology
Summary Background The prognosis of malignant gliomas remains poor. In recurrent disease, chemotherapy can be considered. Patients and methods In this phase II study we determined the anti-tumour efficacy of paclitaxel 200 mg/m2 in a three-hour intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7696ed0701b0ece8bb23b7f712b4e34a
https://doi.org/10.1023/a:1008376123066
https://doi.org/10.1023/a:1008376123066
Autor:
H M, Pinedo, J, Buter, S A, Luykx-de Bakker, P R, Pohlmann, Y, van Hensbergen, D A M, Heideman, P J, van Diest, T D, de Gruijl, E, van der Wall
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(8)
The effect of long-term administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) on dendritic cell (DC) activation and survival in patients with locally advanced breast cancer (LABC) was studied. To this end, the number of activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43bbd529c261e0e4114c472c002e513a
https://pubmed.ncbi.nlm.nih.gov/12736101
https://pubmed.ncbi.nlm.nih.gov/12736101
Autor:
B W, Tillman, T D, de Gruijl, S A, Luykx-de Bakker, R J, Scheper, H M, Pinedo, T J, Curiel, W R, Gerritsen, D T, Curiel
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 162(11)
Important therapeutic applications of genetically modified dendritic cells (DC) have been proposed; however, current vector systems have demonstrated only limited gene delivery efficacy to this cell type. By means of bispecific Abs, we have dramatica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::092b4eb1193c4f9eea117619f326f4af
https://pubmed.ncbi.nlm.nih.gov/10352250
https://pubmed.ncbi.nlm.nih.gov/10352250
Autor:
A H, Honkoop, S A, Luykx-de Bakker, K, Hoekman, S, Meyer, O W, Meyer, C J, van Groeningen, P J, van Diest, E, Boven, E, van der Wall, G, Giaccone, J, Wagstaff, H M, Pinedo
Publikováno v:
The oncologist. 4(2)
Neoadjuvant chemotherapy improves survival in patients with locally advanced breast cancer (LABC). Usually three to four cycles of conventional-dose neoadjuvant chemotherapy are administered prior to local therapy, and another three cycles thereafter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3f622ef265e64cde3a630ae81bae2ca
https://pubmed.ncbi.nlm.nih.gov/10337380
https://pubmed.ncbi.nlm.nih.gov/10337380
Publikováno v:
Luykx-De Bakker, S A, Verheul, H M W, De Gruijl, T D & Pinedo, H M 1999, ' Prolonged neoadjuvant treatment in locally advanced tumours : A novel concept based on biological considerations ', Annals of Oncology, vol. 10, no. 2, pp. 155-160 . https://doi.org/10.1023/A:1008360314669
Annals of Oncology, 10(2), 155-160. Oxford University Press
Annals of Oncology, 10(2), 155-160. Oxford University Press
Summary Background: Neoadjuvant chemotherapy is increasingly applied in patients with locally advanced cancers of many tumour types. Usually three cycles of chemotherapy are administered to reduce the tumour size prior to local therapy, and another t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eae9ec4afc01b5a8cea461954dbc9d2
https://research.vumc.nl/en/publications/1b54c551-5990-4013-8d04-836cdcc50a28
https://research.vumc.nl/en/publications/1b54c551-5990-4013-8d04-836cdcc50a28
